February 13, 2025 - 02:27

The Senate Finance Committee approved President Donald Trump’s choice to be America’s top trade negotiator on Wednesday, largely along party lines. Jamieson Greer, who has been nominated for the position, is expected to play a crucial role in shaping U.S. trade policy during a time of significant global economic challenges.
The committee's vote reflects the ongoing partisan divide in Congress, with most Republicans supporting Greer's nomination while Democrats expressed concerns about his previous positions and the potential impact on American workers. Greer is known for his experience in international trade and has previously worked in various capacities within the U.S. Trade Representative's office.
As the new trade negotiator, Greer will be tasked with navigating complex trade relationships and addressing issues such as tariffs and trade agreements that have become increasingly contentious. His appointment may also influence ongoing negotiations with key trading partners and could have lasting implications for the U.S. economy.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...